Polyethylene Glycol 3350 API / Polyethylene Glycol 4000 API

Polyethylene Glycol 3350 API / Polyethylene Glycol 4000 API
Product Description

By precise polymerization technology and advanced refining post-processing technology to ensure batch-to-batch repeatability.
Spray granulation process gives good flowability, and the particle size can be customized according to the requirements of clients.
The product quality meets the domestic and foreign pharmacopoeia specifications.
Comprehensive research and control on process by-products and degradation impurities.
Complete evaluation, research and control of mutagenic impurities to ensure drug safety.
Investigate and control elemental impurities according to ICH Q3D guidelines.
The accelerated and long-term stability tests indicated good stability of the products

NANJING WELL PHARMACEUTICAL GROUP CO.,LTD.

  • CN
  • 2023
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
Cosmetic Ingredients
Finished Formulation products Distributor/Buyer
Ingredients Distributor/Buyer
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Specifications
  • CAS Registry Number
    25322-68-3
  • Details
    Polyethylene Glycol 3350 conforms to USP/EP

    Polyethylene Glycol 4000 conforms to USP/EP/JP/CHP
  • Selling Points
    Experienced Technicians; Price; Product Performance
  • Supplied from
    China

NANJING WELL PHARMACEUTICAL GROUP CO.,LTD.

  • CN
  • 2023
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Pharmaceutical company
Primary activities
Biopharmaceutical
Cosmetic Ingredients
Finished Formulation products Distributor/Buyer
Ingredients Distributor/Buyer
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

More Products from NANJING WELL PHARMACEUTICAL GROUP CO.,LTD. (4)

  • MPLA (Monophosphoryl Lipid A)

    Product MPLA (Monophosphoryl Lipid A)

    MPLA (Monophosphoryl Lipid A) refers to monophosphoryl lipid A, an effective, safe and non-toxic vaccine adjuvant. It is a highly specific TLR4 agonist that can activate the natural immune response, induce the production of cytokines, and increase the antigen uptake, antigen presentation and activation of ...
  • Poloxamer 188 / Poloxamer 407

    Product Poloxamer 188 / Poloxamer 407

    Emulsifier, solubilizer, wetting agent and suspension stabilizer for liquid oral and topical preparations.

    Can be used as a coating plasticizer for oral solid preparations.

    As gel base for liquid or semi-solid formulations.

  • Polysorbate 80(For Injection)

    Product Polysorbate 80(For Injection)

    Nonionic surfactant, solubilizer, wetting agent, plasticizer. It also can be used as oil-in-water emulsifier.

  • QS-21

    Product QS-21

    QS-21 is an isomeric saponin extracted from the bark of the soap tree (Quillaja Saponaria). It consists of one or more hydrophilic glycoside groups connected to lipophilic triterpenoid derivatives, and contains about 65% QS-21-apiose and 35% QS-21-xylose. Its function is to stimulate antibody-based and cel...